These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23197262)

  • 1. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection.
    Hamada H; Bassity E; Flies A; Strutt TM; Garcia-Hernandez Mde L; McKinstry KK; Zou T; Swain SL; Dutton RW
    J Immunol; 2013 Jan; 190(1):296-306. PubMed ID: 23197262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.
    Hamada H; Garcia-Hernandez Mde L; Reome JB; Misra SK; Strutt TM; McKinstry KK; Cooper AM; Swain SL; Dutton RW
    J Immunol; 2009 Mar; 182(6):3469-81. PubMed ID: 19265125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.
    Garcia-Hernandez Mde L; Hamada H; Reome JB; Misra SK; Tighe MP; Dutton RW
    J Immunol; 2010 Apr; 184(8):4215-27. PubMed ID: 20237297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection.
    Verbist KC; Cole CJ; Field MB; Klonowski KD
    J Immunol; 2011 Jan; 186(1):174-82. PubMed ID: 21098221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus.
    Hashem AM; Gravel C; Chen Z; Yi Y; Tocchi M; Jaentschke B; Fan X; Li C; Rosu-Myles M; Pereboev A; He R; Wang J; Li X
    J Immunol; 2014 Jul; 193(2):722-34. PubMed ID: 24928989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.
    Robinson DP; Hall OJ; Nilles TL; Bream JH; Klein SL
    J Virol; 2014 May; 88(9):4711-20. PubMed ID: 24522912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis.
    Hollenbaugh JA; Reome J; Dobrzanski M; Dutton RW
    J Immunol; 2004 Aug; 173(3):1738-43. PubMed ID: 15265903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.
    Wiley JA; Cerwenka A; Harkema JR; Dutton RW; Harmsen AG
    Am J Pathol; 2001 Jan; 158(1):119-30. PubMed ID: 11141485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 T cells utilize TRAIL to control influenza virus infection.
    Brincks EL; Katewa A; Kucaba TA; Griffith TS; Legge KL
    J Immunol; 2008 Oct; 181(7):4918-25. PubMed ID: 18802095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice.
    Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
    J Innate Immun; 2014; 6(4):456-66. PubMed ID: 24435166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms.
    McKinstry KK; Strutt TM; Kuang Y; Brown DM; Sell S; Dutton RW; Swain SL
    J Clin Invest; 2012 Aug; 122(8):2847-56. PubMed ID: 22820287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell intrinsic NOD2 is dispensable for CD8 T cell immunity.
    Lin GH; Wortzman ME; Girardin SE; Philpott DJ; Watts TH
    PLoS One; 2013; 8(2):e56014. PubMed ID: 23405246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
    Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
    J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
    Brincks EL; Gurung P; Langlois RA; Hemann EA; Legge KL; Griffith TS
    J Immunol; 2011 Nov; 187(9):4581-8. PubMed ID: 21940678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.
    Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M
    Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
    Kemp RA; Ronchese F
    J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.